Atlas Trials

Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma

Clinical trial NCT00163748 · COMPLETED

Trial details

NCT number
NCT00163748
Sponsor
Bayside Health
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Hodgkin's LymphomaHodgkin's Disease
Start date
2001-02-01
Primary completion
2003-11-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.